According to our (Global Info Research) latest study, the global Flu Vaccine market size was valued at USD 5664.4 million in 2023 and is forecast to a readjusted size of USD 7756.9 million by 2030 with a CAGR of 4.6% during review period.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)
https://www.globalinforesearch.com/reports/1651940/flu-vaccine
The research report encompasses the prevailing trends embraced by major manufacturers in the Flu Vaccine Market, such as the adoption of innovative technologies, government investments in research and development, and a growing emphasis on sustainability. Moreover, our research team has furnished essential data to illuminate the manufacturer's role within the regional and global markets.
The research study includes profiles of leading companies operating in the Flu Vaccine Market:
The report is structured into chapters, with an introductory executive summary providing historical and estimated global market figures. This section also highlights the segments and reasons behind their progression or decline during the forecast period. Our insightful Flu Vaccine Market report incorporates Porter's five forces analysis and SWOT analysis to decipher the factors influencing consumer and supplier behavior.
Segmenting the Flu Vaccine Market by application, type, service, technology, and region, each chapter offers an in-depth exploration of market nuances. This segment-based analysis provides readers with a closer look at market opportunities and threats while considering the political dynamics that may impact the market. Additionally, the report scrutinizes evolving regulatory scenarios to make precise investment projections, assesses the risks for new entrants, and gauges the intensity of competitive rivalry.
Flu Vaccine Market by Type: Trivalent Influenza Vaccine、Quadrivalent Influenza Vaccine
Flu Vaccine Market by Application: For Children (6 months to 3 years)、For Adults and Children over 3 years
Key Profits for Industry Members and Stakeholders:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period.
- Which regulatory trends at corporate-level, business-level, and functional-level strategies.
- Which are the End-User technologies being used to capture new revenue streams in the near future.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- One can increase a thorough grasp of market dynamics by looking at prices as well as the actions of producers and users.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Flu Vaccine, with price, sales, revenue and global market share of Flu Vaccine from 2019 to 2024.
Chapter 3, the Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Flu Vaccine.
Chapter 14 and 15, to describe Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
About Us:
GlobaI Info Research
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
